Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Feb;62(2):232–244. doi: 10.1086/301729

Characterization of mutations in patients with multiple endocrine neoplasia type 1.

J H Bassett 1, S A Forbes 1, A A Pannett 1, S E Lloyd 1, P T Christie 1, C Wooding 1, B Harding 1, G M Besser 1, C R Edwards 1, J P Monson 1, J Sampson 1, J A Wass 1, M H Wheeler 1, R V Thakker 1
PMCID: PMC1376903  PMID: 9463336

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by tumors of the parathyroids, pancreatic islets, and anterior pituitary. The MEN1 gene, on chromosome 11q13, has recently been cloned, and mutations have been identified. We have characterized such MEN1 mutations, assessed the reliability of SSCP analysis for the detection of these mutations, and estimated the age-related penetrance for MEN1. Sixty-three unrelated MEN1 kindreds (195 affected and 396 unaffected members) were investigated for mutations in the 2,790-bp coding region and splice sites, by SSCP and DNA sequence analysis. We identified 47 mutations (12 nonsense mutations, 21 deletions, 7 insertions, 1 donor splice-site mutation, and 6 missense mutations), that were scattered throughout the coding region, together with six polymorphisms that had heterozygosity frequencies of 2%-44%. More than 10% of the mutations arose de novo, and four mutation hot spots accounted for >25% of the mutations. SSCP was found to be a sensitive and specific mutational screening method that detected >85% of the mutations. Two hundred and one MEN1 mutant-gene carriers (155 affected and 46 unaffected) were identified, and these helped to define the age-related penetrance of MEN1 as 7%, 52%, 87%, 98%, 99%, and 100% at 10, 20, 30, 40, 50, and 60 years of age, respectively. These results provide the basis for a molecular-genetic screening approach that will supplement the clinical evaluation and genetic counseling of members of MEN1 families.

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal S. K., Kester M. B., Debelenko L. V., Heppner C., Emmert-Buck M. R., Skarulis M. C., Doppman J. L., Kim Y. S., Lubensky I. A., Zhuang Z. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997 Jul;6(7):1169–1175. doi: 10.1093/hmg/6.7.1169. [DOI] [PubMed] [Google Scholar]
  2. Blanquet V., Turleau C., Gross-Morand M. S., Sénamaud-Beaufort C., Doz F., Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet. 1995 Mar;4(3):383–388. doi: 10.1093/hmg/4.3.383. [DOI] [PubMed] [Google Scholar]
  3. Brown M. A., Solomon E. Studies on inherited cancers: outcomes and challenges of 25 years. Trends Genet. 1997 May;13(5):202–206. doi: 10.1016/s0168-9525(97)01132-3. [DOI] [PubMed] [Google Scholar]
  4. Chandrasekharappa S. C., Guru S. C., Manickam P., Olufemi S. E., Collins F. S., Emmert-Buck M. R., Debelenko L. V., Zhuang Z., Lubensky I. A., Liotta L. A. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997 Apr 18;276(5311):404–407. doi: 10.1126/science.276.5311.404. [DOI] [PubMed] [Google Scholar]
  5. Cooper D. N., Krawczak M. Mechanisms of insertional mutagenesis in human genes causing genetic disease. Hum Genet. 1991 Aug;87(4):409–415. doi: 10.1007/BF00197158. [DOI] [PubMed] [Google Scholar]
  6. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nat Genet. 1993 Oct;5(2):111–117. doi: 10.1038/ng1093-111. [DOI] [PubMed] [Google Scholar]
  7. Krawczak M., Cooper D. N. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet. 1991 Mar;86(5):425–441. doi: 10.1007/BF00194629. [DOI] [PubMed] [Google Scholar]
  8. Larsson C., Calender A., Grimmond S., Giraud S., Hayward N. K., Teh B., Farnebo F. Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. J Intern Med. 1995 Sep;238(3):239–244. doi: 10.1111/j.1365-2796.1995.tb00929.x. [DOI] [PubMed] [Google Scholar]
  9. Larsson C., Shepherd J., Nakamura Y., Blomberg C., Weber G., Werelius B., Hayward N., Teh B., Tokino T., Seizinger B. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest. 1992 Apr;89(4):1344–1349. doi: 10.1172/JCI115720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Larsson C., Skogseid B., Oberg K., Nakamura Y., Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 1988 Mar 3;332(6159):85–87. doi: 10.1038/332085a0. [DOI] [PubMed] [Google Scholar]
  11. Lloyd S. E., Pearce S. H., Fisher S. E., Steinmeyer K., Schwappach B., Scheinman S. J., Harding B., Bolino A., Devoto M., Goodyer P. A common molecular basis for three inherited kidney stone diseases. Nature. 1996 Feb 1;379(6564):445–449. doi: 10.1038/379445a0. [DOI] [PubMed] [Google Scholar]
  12. Lloyd S. E., Pearce S. H., Günther W., Kawaguchi H., Igarashi T., Jentsch T. J., Thakker R. V. Idiopathic low molecular weight proteinuria associated with hypercalciuric nephrocalcinosis in Japanese children is due to mutations of the renal chloride channel (CLCN5). J Clin Invest. 1997 Mar 1;99(5):967–974. doi: 10.1172/JCI119262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lohmann D. R., Brandt B., Höpping W., Passarge E., Horsthemke B. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet. 1996 May;58(5):940–949. [PMC free article] [PubMed] [Google Scholar]
  14. Pang J. T., Lloyd S. E., Wooding C., Farren B., Pottinger B., Harding B., Leigh S. E., Pook M. A., Benham F. J., Gillett G. T. Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene. Hum Genet. 1996 Jun;97(6):732–741. doi: 10.1007/BF02346182. [DOI] [PubMed] [Google Scholar]
  15. Pang J. T., Thakker R. V. Multiple endocrine neoplasia type 1 (MEN1). Eur J Cancer. 1994;30A(13):1961–1968. doi: 10.1016/0959-8049(94)00387-k. [DOI] [PubMed] [Google Scholar]
  16. Pearce S. H., Trump D., Wooding C., Besser G. M., Chew S. L., Grant D. B., Heath D. A., Hughes I. A., Paterson C. R., Whyte M. P. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest. 1995 Dec;96(6):2683–2692. doi: 10.1172/JCI118335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ripley L. S., Clark A., deBoer J. G. Spectrum of spontaneous frameshift mutations. Sequences of bacteriophage T4 rII gene frameshifts. J Mol Biol. 1986 Oct 20;191(4):601–613. doi: 10.1016/0022-2836(86)90448-1. [DOI] [PubMed] [Google Scholar]
  18. Stock J. L., Warth M. R., Teh B. T., Coderre J. A., Overdorf J. H., Baumann G., Hintz R. L., Hartman M. L., Seizinger B. R., Larsson C. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13. J Clin Endocrinol Metab. 1997 Feb;82(2):486–492. doi: 10.1210/jcem.82.2.3730. [DOI] [PubMed] [Google Scholar]
  19. Thakker R. V., Bouloux P., Wooding C., Chotai K., Broad P. M., Spurr N. K., Besser G. M., O'Riordan J. L. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med. 1989 Jul 27;321(4):218–224. doi: 10.1056/NEJM198907273210403. [DOI] [PubMed] [Google Scholar]
  20. Thakker R. V., Pook M. A., Wooding C., Boscaro M., Scanarini M., Clayton R. N. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest. 1993 Jun;91(6):2815–2821. doi: 10.1172/JCI116524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Thakker R. V. The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol (Oxf) 1993 Jan;38(1):1–14. doi: 10.1111/j.1365-2265.1993.tb00964.x. [DOI] [PubMed] [Google Scholar]
  22. Trump D., Farren B., Wooding C., Pang J. T., Besser G. M., Buchanan K. D., Edwards C. R., Heath D. A., Jackson C. E., Jansen S. Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM. 1996 Sep;89(9):653–669. doi: 10.1093/qjmed/89.9.653. [DOI] [PubMed] [Google Scholar]
  23. Varmus H. E. The molecular genetics of cellular oncogenes. Annu Rev Genet. 1984;18:553–612. doi: 10.1146/annurev.ge.18.120184.003005. [DOI] [PubMed] [Google Scholar]
  24. WERMER P. Genetic aspects of adenomatosis of endocrine glands. Am J Med. 1954 Mar;16(3):363–371. doi: 10.1016/0002-9343(54)90353-8. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES